Alexion Pharmaceuticals, Inc.
Monovalent anti-properdin antibodies and antibody fragments

Last updated:

Abstract:

Described herein are isolated monovalent antibodies or antibody fragments thereof that bind human properdin. Such antibodies are useful in methods of treatment for diseases mediated by alternative complement pathway dysregulation.

Status:
Grant
Type:

Utility

Filling date:

30 Jan 2018

Issue date:

14 Dec 2021